These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38175687)

  • 1. Signatures of tumor-associated macrophages correlate with treatment response in ovarian cancer patients.
    Gao Y; Qi Y; Shen Y; Zhang Y; Wang D; Su M; Liu X; Wang A; Zhang W; He C; Yang J; Dai M; Wang H; Cai H
    Aging (Albany NY); 2024 Jan; 16(1):207-225. PubMed ID: 38175687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.
    El-Arabey AA; Denizli M; Kanlikilicer P; Bayraktar R; Ivan C; Rashed M; Kabil N; Ozpolat B; Calin GA; Salama SA; Abd-Allah AR; Sood AK; Lopez-Berestein G
    Cell Signal; 2020 Apr; 68():109539. PubMed ID: 31935430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer.
    Gao L; Ying F; Cai J; Peng M; Xiao M; Sun S; Zeng Y; Xiong Z; Cai L; Gao R; Wang Z
    J Ovarian Res; 2023 Jan; 16(1):27. PubMed ID: 36707884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analyses Identify APOBEC3A as a Genomic Instability-Associated Immune Prognostic Biomarker in Ovarian Cancer.
    Xu F; Liu T; Zhou Z; Zou C; Xu S
    Front Immunol; 2021; 12():749369. PubMed ID: 34745121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting macrophages in ovarian cancer microenvironment: development, function and interaction.
    El-Arabey AA; Alkhalil SS; Al-Shouli ST; Awadalla ME; Alhamdi HW; Almanaa TN; Mohamed SSEM; Abdalla M
    Med Oncol; 2023 Apr; 40(5):142. PubMed ID: 37039909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
    Leung D; Price ZK; Lokman NA; Wang W; Goonetilleke L; Kadife E; Oehler MK; Ricciardelli C; Kannourakis G; Ahmed N
    J Transl Med; 2022 Dec; 20(1):556. PubMed ID: 36463238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.
    Hu Z; Sui Q; Jin X; Shan G; Huang Y; Yi Y; Zeng D; Zhao M; Zhan C; Wang Q; Lin Z; Lu T; Chen Z
    J Exp Clin Cancer Res; 2024 Feb; 43(1):63. PubMed ID: 38424624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes.
    Ardighieri L; Missale F; Bugatti M; Gatta LB; Pezzali I; Monti M; Gottardi S; Zanotti L; Bignotti E; Ravaggi A; Tognon G; Odicino F; Calza S; Missolo-Koussou Y; Ries CH; Helft J; Vermi W
    Front Immunol; 2021; 12():690201. PubMed ID: 34220848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer-specific dysregulated genes with prognostic significance: scRNA-Seq with bulk RNA-Seq data and experimental validation.
    Liu C; Zhang Y; Li X; Wang D
    Ann N Y Acad Sci; 2022 Jun; 1512(1):154-173. PubMed ID: 35247207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An EMT-based gene signature enhances the clinical understanding and prognostic prediction of patients with ovarian cancers.
    Li QJ; Wu ZL; Wang J; Jiang J; Lin B
    J Ovarian Res; 2023 Mar; 16(1):51. PubMed ID: 36907877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition.
    Amoroso MR; Matassa DS; Agliarulo I; Avolio R; Lu H; Sisinni L; Lettini G; Gabra H; Landriscina M; Esposito F
    Cell Death Dis; 2016 Dec; 7(12):e2522. PubMed ID: 27977010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Notch-Related Gene Signature for Prognosis and Immune Response Prediction in Ovarian Cancer.
    Pi Y; Sun F; Zhang Z; Liu X; Lou G
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512088
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of STEAP3-based molecular subtype and risk model in ovarian cancer.
    Zhao Z; Sun C; Hou J; Yu P; Wei Y; Bai R; Yang P
    J Ovarian Res; 2023 Jun; 16(1):126. PubMed ID: 37386521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the immune microenvironment for ovarian cancer therapy.
    Blanc-Durand F; Clemence Wei Xian L; Tan DSP
    Front Immunol; 2023; 14():1328651. PubMed ID: 38164130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of immune microenvironment in ovarian cancer and its clinical significance: a retrospective study.
    Gao Y; Chen L; Cai G; Xiong X; Wu Y; Ma D; Li SC; Gao Q
    Oncoimmunology; 2020; 9(1):1760067. PubMed ID: 32391193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling.
    Chen X; Yang M; Yin J; Li P; Zeng S; Zheng G; He Z; Liu H; Wang Q; Zhang F; Chen D
    Cell Commun Signal; 2022 Jun; 20(1):92. PubMed ID: 35715860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial interaction and functional status of CD68
    Liu X; Zhang Z; Yuan J; Yu J; Chen D
    Front Immunol; 2024; 15():1396719. PubMed ID: 38799432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated macrophages induce the expression of FOXQ1 to promote epithelial-mesenchymal transition and metastasis in gastric cancer cells.
    Guo J; Yan Y; Yan Y; Guo Q; Zhang M; Zhang J; Goltzman D
    Oncol Rep; 2017 Oct; 38(4):2003-2010. PubMed ID: 28791370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paeoniflorigenone inhibits ovarian cancer metastasis through targeting the MUC1/Wnt/β‑catenin pathway.
    Liu Q; Jiang L; Zhao Y; Su F; Li J; Tian X; Liu W; Jiang X; Xu Y; Tao F
    Int J Mol Med; 2024 Jul; 54(1):. PubMed ID: 38785138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.